- Home
- GSIW vs ALBT Comparison
GSIW vs ALBT Comparison
Compare GSIW & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- ALBT
- Stock Information
- Founded
- GSIW 2016
- ALBT 2014
- Country
- GSIW Hong Kong
- ALBT United States
- Employees
- GSIW N/A
- ALBT N/A
- Industry
- GSIW
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GSIW
- ALBT Health Care
- Exchange
- GSIW Nasdaq
- ALBT Nasdaq
- Market Cap
- GSIW 8.1M
- ALBT 7.4M
- IPO Year
- GSIW 2023
- ALBT N/A
- Fundamental
- Price
- GSIW $0.18
- ALBT $2.34
- Analyst Decision
- GSIW
- ALBT
- Analyst Count
- GSIW 0
- ALBT 0
- Target Price
- GSIW N/A
- ALBT N/A
- AVG Volume (30 Days)
- GSIW 13.8M
- ALBT 64.9K
- Earning Date
- GSIW 01-01-0001
- ALBT 11-11-2025
- Dividend Yield
- GSIW N/A
- ALBT N/A
- EPS Growth
- GSIW N/A
- ALBT N/A
- EPS
- GSIW N/A
- ALBT N/A
- Revenue
- GSIW $5,368,221.00
- ALBT $1,159,091.00
- Revenue This Year
- GSIW N/A
- ALBT N/A
- Revenue Next Year
- GSIW N/A
- ALBT N/A
- P/E Ratio
- GSIW N/A
- ALBT N/A
- Revenue Growth
- GSIW 283.23
- ALBT N/A
- 52 Week Low
- GSIW $0.09
- ALBT $1.87
- 52 Week High
- GSIW $2.59
- ALBT $11.66
- Technical
- Relative Strength Index (RSI)
- GSIW 54.81
- ALBT 46.40
- Support Level
- GSIW $0.14
- ALBT $2.20
- Resistance Level
- GSIW $0.16
- ALBT $2.55
- Average True Range (ATR)
- GSIW 0.02
- ALBT 0.12
- MACD
- GSIW 0.01
- ALBT -0.04
- Stochastic Oscillator
- GSIW 91.84
- ALBT 24.35
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.